Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03767-4
Abstract: The aim of this retrospective study was to compare the clinical outcomes of pembrolizumab-lenvatinib-transarterial chemoembolization (TACE) versus lenvatinib-TACE sequential therapy in selected populations of Chinese patients with initially unresectable hepatocellular carcinoma (uHCC) harbouring programmed cell… read more here.
Keywords: tace; lenvatinib tace; tace group; study ... See more keywords
Evaluation of Transarterial Chemoembolization Protocol with Drug-Eluting Beads in Combination with Lipiodol for Hepatocellular Carcinoma: A Single-Center Controlled Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/1090313
Abstract: Objectives To evaluate the efficacy and safety of transarterial chemoembolization (TACE) with drug-eluting beads (DEB-TACE) and lipiodol (DEB-Lipiodol TACE) in the treatment of unresectable hepatocellular carcinoma (HCC) patients. Materials and Methods The medical records of… read more here.
Keywords: tace; months months; deb lipiodol; lipiodol tace ... See more keywords
Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Anti-Cancer Agents in Medicinal Chemistry"
DOI: 10.2174/1871520622666220601115458
Abstract: Purpose To investigate the safety and efficacy of lobaplatin-TACE in treating primary hepatocellular carcinoma. Methods The data of 536 patients who underwent TACE in the interventional department from January 2016 to January 2020 were collected.… read more here.
Keywords: epirubicin tace; tace; tace group; lobaplatin tace ... See more keywords
Comparison of CalliSpheres® Microspheres Drug-eluting Beads and Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2023 at "Radiology and Oncology"
DOI: 10.2478/raon-2023-0001
Abstract: Abstract Background This trial aimed to compare the outcomes of drug-eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres® microspheres (CSM) and conventional transarterial chemoembolization cTACE in the treatment of patients with unresectable hepatocellular carcinoma (HCC). Patients… read more here.
Keywords: deb tace; ctace group; group; transarterial chemoembolization ... See more keywords
Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.835889
Abstract: Objective This study was conducted in order to compare the efficacy and safety of transarterial chemoembolization (TACE) plus apatinib plus camrelizumab (TACE+AC) and apatinib plus camrelizumab (AC) in the treatment of unresectable hepatocellular carcinoma (HCC)… read more here.
Keywords: hepatocellular carcinoma; plus camrelizumab; apatinib plus; group ... See more keywords
Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1057560
Abstract: Purpose To compare the effectiveness and safety of transarterial chemoembolization (TACE) combined with apatinib and camrelizumab with those of TACE as well as apatinib among patients with unresectable hepatocellular carcinoma (HCC). Materials and methods The… read more here.
Keywords: hepatocellular carcinoma; tace; camrelizumab; tace group ... See more keywords
Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.945915
Abstract: Purpose We conducted a retrospective study to compare transarterial chemoembolization (TACE) plus lenvatinib plus programmed death-1 (PD-1) inhibitors with TACE plus lenvatinib in patients with unresectable hepatocellular carcinoma (HCC). Patients and methods Patients with HCC… read more here.
Keywords: plus lenvatinib; tace; patients unresectable; transarterial chemoembolization ... See more keywords
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1074793
Abstract: Background The combination of tyrosine kinase inhibitors (TKIs) and transarterial chemoembolization (TACE) fulfills an important role in the treatment of unresectable hepatocellular carcinoma (uHCC). Among the combination therapies, both lenvatinib and sorafenib combined with TACE… read more here.
Keywords: tace; sor tace; transarterial chemoembolization; tace group ... See more keywords